G. BABUNA KOBANER And A. KUTLAY, "Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center," 4th INDERCOS Congress , İstanbul, Turkey, pp.221, 2019
BABUNA KOBANER, G. And KUTLAY, A. 2019. Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center. 4th INDERCOS Congress , (İstanbul, Turkey), 221.
BABUNA KOBANER, G., & KUTLAY, A., (2019). Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center . 4th INDERCOS Congress (pp.221). İstanbul, Turkey
BABUNA KOBANER, Goncagül, And Armağan KUTLAY. "Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center," 4th INDERCOS Congress, İstanbul, Turkey, 2019
BABUNA KOBANER, Goncagül B. And KUTLAY, Armağan. "Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center." 4th INDERCOS Congress , İstanbul, Turkey, pp.221, 2019
BABUNA KOBANER, G. And KUTLAY, A. (2019) . "Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center." 4th INDERCOS Congress , İstanbul, Turkey, p.221.
@conferencepaper{conferencepaper, author={Goncagül BABUNA KOBANER And author={Armağan KUTLAY}, title={Long-Term Efficacy and Safety of Infliximab for Psoriasis: Twelve-Year Experience in A Single Tertiary Center}, congress name={4th INDERCOS Congress}, city={İstanbul}, country={Turkey}, year={2019}, pages={221} }